These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 15464635)

  • 1. Age and antiepileptic drugs influence topiramate plasma levels in children.
    Dahlin MG; Ohman IK
    Pediatr Neurol; 2004 Oct; 31(4):248-53. PubMed ID: 15464635
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Age and comedications influence levetiracetam pharmacokinetics in children.
    Dahlin MG; Wide K; Ohman I
    Pediatr Neurol; 2010 Oct; 43(4):231-5. PubMed ID: 20837299
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacokinetic-pharmacodynamic assessment of topiramate dosing regimens for children with epilepsy 2 to <10 years of age.
    Girgis IG; Nandy P; Nye JS; Ford L; Mohanty S; Wang S; Ochalski S; Eerdekens M; Cox E
    Epilepsia; 2010 Oct; 51(10):1954-62. PubMed ID: 20880232
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacokinetic variability of four newer antiepileptic drugs, lamotrigine, levetiracetam, oxcarbazepine, and topiramate: a comparison of the impact of age and comedication.
    Johannessen Landmark C; Baftiu A; Tysse I; Valsø B; Larsson PG; Rytter E; Johannessen SI
    Ther Drug Monit; 2012 Aug; 34(4):440-5. PubMed ID: 22777154
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Topiramate pharmacokinetics in children and adults with epilepsy: a case-matched comparison based on therapeutic drug monitoring data.
    Battino D; Croci D; Rossini A; Messina S; Mamoli D; Perucca E
    Clin Pharmacokinet; 2005; 44(4):407-16. PubMed ID: 15828853
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Topiramate therapeutic monitoring in patients with epilepsy: effect of concomitant antiepileptic drugs.
    Contin M; Riva R; Albani F; Avoni P; Baruzzi A
    Ther Drug Monit; 2002 Jun; 24(3):332-7. PubMed ID: 12021622
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Topiramate pharmacokinetics in children with epilepsy aged from 6 months to 4 years.
    Mikaeloff Y; Rey E; Soufflet C; d'Athis P; Echenne B; Vallée L; Bouhours P; Grinspan A; Dulac O; Pons G; Chiron C
    Epilepsia; 2004 Nov; 45(11):1448-52. PubMed ID: 15509246
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serum concentrations of topiramate in patients with epilepsy: influence of dose, age, and comedication.
    May TW; Rambeck B; Jürgens U
    Ther Drug Monit; 2002 Jun; 24(3):366-74. PubMed ID: 12021627
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacokinetics and safety of adjunctive topiramate in infants (1-24 months) with refractory partial-onset seizures: a randomized, multicenter, open-label phase 1 study.
    Manitpisitkul P; Shalayda K; Todd M; Wang SS; Ness S; Ford L
    Epilepsia; 2013 Jan; 54(1):156-64. PubMed ID: 23157581
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Topiramate serum concentration-to-dose ratio: influence of age and concomitant antiepileptic drugs and monitoring implications.
    Adín J; Gómez MC; Blanco Y; Herranz JL; Armijo JA
    Ther Drug Monit; 2004 Jun; 26(3):251-7. PubMed ID: 15167623
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Rufinamide in children with refractory epilepsy: pharmacokinetics, efficacy, and safety.
    Dahlin MG; Ohman I
    Neuropediatrics; 2012 Oct; 43(5):264-70. PubMed ID: 22941776
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of antiepileptic drug comedication on lamotrigine concentrations.
    Lovrić M; Čajić I; Petelin Gadže Ž; Klarica Domjanović I; Božina N
    Croat Med J; 2018 Feb; 59(1):13-19. PubMed ID: 29498493
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Influence of dosage, age, and co-medication on plasma topiramate concentrations in children and adults with severe epilepsy and preliminary observations on correlations with clinical response.
    Ferrari AR; Guerrini R; Gatti G; Alessandrì MG; Bonanni P; Perucca E
    Ther Drug Monit; 2003 Dec; 25(6):700-8. PubMed ID: 14639056
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lack of pharmacokinetic interaction of levetiracetam on carbamazepine, valproic acid, topiramate, and lamotrigine in children with epilepsy.
    Otoul C; De Smedt H; Stockis A
    Epilepsia; 2007 Nov; 48(11):2111-5. PubMed ID: 17651416
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A study of topiramate pharmacokinetics and tolerability in children with epilepsy.
    Rosenfeld WE; Doose DR; Walker SA; Baldassarre JS; Reife RA
    Pediatr Neurol; 1999 May; 20(5):339-44. PubMed ID: 10371378
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical experience with topiramate dosing and serum levels in children 12 years or under with epilepsy.
    Schwabe MJ; Wheless JW
    J Child Neurol; 2001 Nov; 16(11):806-8. PubMed ID: 11732765
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The influence of old age and enzyme inducing comedication on the pharmacokinetics of valproic acid at steady-state: A case-matched evaluation based on therapeutic drug monitoring data.
    Fattore C; Messina S; Battino D; Croci D; Mamoli D; Perucca E
    Epilepsy Res; 2006 Aug; 70(2-3):153-60. PubMed ID: 16730950
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical experience with topiramate dosing and serum levels in patients with epilepsy.
    Zanotta N; Raggi ME; Radice L; Degrate A; Bresolin N; Zucca C
    Seizure; 2006 Mar; 15(2):86-92. PubMed ID: 16406695
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Rufinamide: clinical pharmacokinetics and concentration-response relationships in patients with epilepsy.
    Perucca E; Cloyd J; Critchley D; Fuseau E
    Epilepsia; 2008 Jul; 49(7):1123-41. PubMed ID: 18503564
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A comparative study of the effect of carbamazepine and valproic acid on the pharmacokinetics and metabolic profile of topiramate at steady state in patients with epilepsy.
    Mimrod D; Specchio LM; Britzi M; Perucca E; Specchio N; La Neve A; Soback S; Levy RH; Gatti G; Doose DR; Maryanoff BE; Bialer M
    Epilepsia; 2005 Jul; 46(7):1046-54. PubMed ID: 16026556
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.